A securities class action has been filed in the USDC — E.D.N.Y. against Agilon Health, Inc. (AGL) (“Agilon” or the “Company”) on behalf of all persons and entities that purchased or otherwise acquired Agilon securities between February 26, 2025, and August 4, 2025, both dates inclusive (the “Class Period”).

Agilon describes itself as the “trusted partner empowering physicians to transform health care in our communities.

The complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

(1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware;

(2) Defendants materially overstated the immediate positive financial impact from “strategic actions” taken by Agilon to reduce risk; and

(3) as a result, defendants’ statements about Agilon’s business, operations, and prospects were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you purchased Agilon securities during the class period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.